Cargando…
Skin manifestations of COVID-19: A worldwide review
OBJECTIVE: Because of the increasing emergence of skin manifestations of COVID-19 worldwide, we investigated the published reports of these lesions. METHODS: We conducted a literature search for original and review articles published from November 11, 2019 to September 30, 2020. RESULTS: We identifi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754879/ https://www.ncbi.nlm.nih.gov/pubmed/33479703 http://dx.doi.org/10.1016/j.jdin.2020.12.003 |
Sumario: | OBJECTIVE: Because of the increasing emergence of skin manifestations of COVID-19 worldwide, we investigated the published reports of these lesions. METHODS: We conducted a literature search for original and review articles published from November 11, 2019 to September 30, 2020. RESULTS: We identified 5 skin lesions common in patients with COVID-19: pseudo-chilblains, rashes containing macules and papules, and urticarial, vesicular, and vaso-occlusive lesions. These lesions manifested at various times in relation to the COVID-19 symptoms, which may indicate whether the lesions are virus-induced or are delayed immunological responses to the infection. Skin lesions were more prevalent among Europeans and United States residents than among Asians, as was pseudo-chilblain, and the morphology of the skin lesions varied among continents. Pseudo-chilblains were the most common COVID-19 skin manifestation in Europe and the United States, but there was only 1 reported case from Asian populations. Additionally, patients with vaso-occlusive lesions were more likely than those with pseudo-chilblains to be admitted to the intensive care unit and to die. CONCLUSION: Different cutaneous manifestations in patients with COVID-19 could reflect a wide spectrum of viral interactions with the skin, though reporting bias may play a role as well. |
---|